Staphylococcus aureus is a major human pathogen that causes a wide range of clinical
infections. It is a leading cause of bacteremia and infective endocarditis as well as …

Importance Several management strategies may improve outcomes in patients
withStaphylococcus aureusbacteremia. Objectives To review evidence of management …

Background. We assessed the impact of infectious disease (ID) consultation on
management and outcome in patients with Staphylococcus aureus bacteremia (SAB) …

Objective Mortality and morbidity of Staphylococcus aureus bacteremia (SAB) still remains
considerably high. We aimed to evaluate the impact of infectious disease consultation (IDC) …

Los antimicrobianos son fármacos distintos al resto. Su eficacia en la reducción de la
morbilidad y la mortalidad es muy superior a la de otros grupos de medicamentos. Por otra …

Background. Staphylococcus aureus bacteremia (SAB) is associated with significant
morbidity and mortality. Several aspects of clinical management have been shown to have …

Background. Previous studies, largely based on chart reviews with small sample sizes, have
demonstrated that infectious diseases (ID) specialists positively impact patient outcomes …

Background. Recent reports have described decreased effectiveness with vancomycin
treatment for methicillin-resistant Staphylococcus aureus bacteremia (MRSAB) when the …

Introduction In the time of increasing resistance and paucity of new drug development there
is a growing need for strategies to enhance rational use of antibiotics in German and …

Background Information on outcomes of methicillin-susceptible and-resistant
Staphylococcus aureus (MSSA and MRSA, respectively) bacteremia, particularly …